Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year. EventsDates2025 annual revenueFebruary 5, 2026 (after market close)2025 annual resultsMarch 30, 2026 (before market opens)2026 Q1 revenueApril 29, 2026 (after market close)Annual General MeetingJune 25, 20262026 Half-year revenueJuly 30, 2026 (after market clos ...

Core Insights - Equasens Group reported revenue of €172.2 million for the period ending September 30, 2025, reflecting an increase of 8.9% on a reported basis and 7.3% like-for-like compared to the same period in 2024 [3][4][23] Revenue Performance - Q3 2025 revenue was particularly strong, with a like-for-like growth of 9.4%, aligning with the Group's targets [4] - Total revenue for Q1, Q2, and Q3 of 2025 was €53.3 million, €54.7 million, and €50.2 million respectively, showing consistent growth across the quarters [2][4] Revenue by Business Segment - Systems and equipment segment saw a significant increase, contributing €69.1 million in 2025, up 13.1% from 2024 [6] - Maintenance and subscriptions segment grew to €77.9 million, a 6.2% increase, while software and services rose to €25.0 million, up 6.4% [6] - Q3 revenue breakdown showed systems and equipment at €22.1 million (+20.7%), maintenance and subscriptions at €26.5 million (+7.6%), and software and services at €7.6 million (+6.2%) [6] Division Performance - The Pharmagest Division reported revenue of €126.6 million, a 5.4% increase, with Q3 revenue at €40.7 million (+7.1%) [10][12] - Axigate Link Division revenue reached €25.3 million (+12.2%) with Q3 at €8.9 million (+23.8%) [16] - E-Connect Division saw substantial growth, reporting €11.4 million (+37.2%) and €3.9 million in Q3 (+38.3%) [18] Strategic Acquisitions and Innovations - Acquisitions contributed €2.4 million to revenue, with Calimed and Novaprove being significant contributors [5][8] - The Group's focus on innovation and European expansion has driven growth, particularly in France, Italy, and Germany [13][14][15] Future Outlook - The Group maintains its guidance for nearly 10% revenue growth on a reported basis for the second half of 2025 [23] - Continued focus on external growth opportunities to enhance service offerings and distribution networks is emphasized [23]

Core Points - Equasens Group will hold its Annual Ordinary General Meeting on June 25, 2025, at 5:30 PM at its registered office in Villers-lès-Nancy [2] - The agenda and resolutions for the meeting were published in the French legal announcements on May 16, 2025 [3] - The Meeting Notice was published on June 6, 2025, detailing participation and voting procedures [4] Company Information - Equasens Group, founded over 35 years ago, is a leader in digital healthcare solutions, employing over 1,300 people across Europe [8] - The company provides specialized business applications that support healthcare professionals in various settings, including private practice and healthcare establishments [9] - Equasens Group focuses on interoperability solutions that enhance coordination among healthcare professionals, improving patient care and system efficiency [10] Meeting Logistics - The Annual General Meeting will be broadcast live online, with connection information available 48 hours prior to the meeting [7] - A replay of the meeting will also be accessible on the company's website for later viewing [7] - All relevant documents and voting forms are available on the company's website since June 4, 2025 [5]